secwatch.observer — SEC 8-K summary
======================================

Issuer:     LQR House Inc. (YHC)
CIK:        0001843165
Form:       8-K/A
Filed at:   2023-08-23T23:59:59+00:00
Accession:  0001213900-23-070186
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Appoints Jay Dhaliwal to Board; Launches Preliminary Naked Short Selling Investigation
--------------------------------------------------------------------------------

- Jay Dhaliwal appointed to Board effective Aug 21, 2023, increasing board from 7 to 8 members.
- Dhaliwal is independent; current CEO of Global Health Clinics and interim CEO of Ravenquest Biomed; serves on several public company boards.
- LQR House will conduct preliminary investigation into possible naked short selling and manipulation of its common shares on NASDAQ.
- Company enters standard indemnity and director agreements, and restricted stock unit award agreement with Dhaliwal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1843165/000121390023070186/0001213900-23-070186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1843165/000121390023070186/ea184091-8ka1_lqrhouse.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-070186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer